IVERMECTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ivermectin, and what generic alternatives are available?
Ivermectin is a drug marketed by Padagis Israel, Teva Pharms Usa, Zydus, Taro, and Edenbridge Pharms. and is included in six NDAs.
The generic ingredient in IVERMECTIN is ivermectin. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ivermectin
A generic version of IVERMECTIN was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.
Summary for IVERMECTIN
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 201 |
| Patent Applications: | 3,081 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for IVERMECTIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for IVERMECTIN |
| What excipients (inactive ingredients) are in IVERMECTIN? | IVERMECTIN excipients list |
| DailyMed Link: | IVERMECTIN at DailyMed |
Recent Clinical Trials for IVERMECTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitas Padjadjaran | Phase 4 |
| Permamed AG, Switzerland | Early Phase 1 |
| Galvita AG, Switzerland | Early Phase 1 |
Pharmacology for IVERMECTIN
| Drug Class | Antiparasitic Pediculicide |
Medical Subject Heading (MeSH) Categories for IVERMECTIN
Anatomical Therapeutic Chemical (ATC) Classes for IVERMECTIN
Paragraph IV (Patent) Challenges for IVERMECTIN
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| SKLICE | Lotion | ivermectin | 0.50% | 202736 | 1 | 2017-09-01 |
| SOOLANTRA | Cream | ivermectin | 1% | 206255 | 1 | 2016-12-30 |
US Patents and Regulatory Information for IVERMECTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225-001 | Apr 13, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Taro | IVERMECTIN | ivermectin | LOTION;TOPICAL | 210720-001 | May 6, 2020 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Teva Pharms Usa | IVERMECTIN | ivermectin | CREAM;TOPICAL | 210019-001 | Sep 13, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Zydus | IVERMECTIN | ivermectin | CREAM;TOPICAL | 215210-001 | Aug 2, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Edenbridge Pharms | IVERMECTIN | ivermectin | TABLET;ORAL | 204154-001 | Oct 24, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms Usa | IVERMECTIN | ivermectin | LOTION;TOPICAL | 212485-001 | Mar 21, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
